QA: Calithera Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001496671_2023_Calithera_Biosciences_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001496671, Calithera Biosciences Inc.

  xvar xval
0 AssetsCurrent 26,624,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 434,000
3 remainder_Assets 1,618,000
4 LiabilitiesCurrent 7,390,000
5 LiabilitiesNoncurrent 136,000
6 remainder_Liabilities 758,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,541,000
9 ResearchAndDevelopmentExpense 28,533,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,424,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 28,676,000
1 Liabilities 8,284,000
2 Expenses 42,074,000
3 Revenues 0
4 StockholdersEquity 20,392,000
5 NetIncome -39,650,000
6 ComprehensiveNetIncome -39,650,000
7 BaseVar 40,729,000
8 EconomicCapitalRatio -0.248

Edgar->Model Mapping

Feature Distribution

Change over Time